Search

everythinglearnresearchcommunity

for

Search:↓

Androstanediol glucuronide is a reliable marker for hirsutism in women.

A woman had a rare liver tumor causing male-like physical changes, highlighting the need for thorough checks when such symptoms appear.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Hair loss is a common side effect of hormone treatments for cancer.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Taking hormonal contraceptives can cause skin changes, including hair loss, due to the effects of synthetic sex hormones.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

Inhibiting 5α-reductase during late pregnancy shortens gestation, reduces litter size, and harms memory in rat offspring.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Finasteride may affect PNMT, causing side effects.

More research is needed on the safety of fathers' drug exposure before conception.

BPH treatments can cause sexual side effects affecting quality of life.

Finasteride can cause gum swelling and bleeding, but stopping the drug helps recovery.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

A rare adrenal tumor in a 14-year-old girl caused male-like symptoms and was successfully removed.

Testosterone and some of its forms can strongly stimulate oil gland growth in skin.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

An ovarian tumor can cause high male hormones in postmenopausal women.

2-Ethylhexanoic acid harms fertility and delays development in rats.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

A postmenopausal woman had rare symptoms due to a possible ovarian tumor, needing thorough evaluation.

Rare seminoma found in a 33-year-old woman with atypical genitalia and no Y chromosome.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.